Paper4121931
Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.
Hahn GM and 3 others. J Natl Cancer Inst, 1973. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure. Papers, record 4121931. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4121931
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Cyclophosphamide | Major topic |
| Fluorouracil | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| Animals | |
| Bleomycin | |
| Cell Survival | |
| Female | |
| Mammary Glands, Animal | |
| Mice | |
| Mice, Inbred BALB C | |
| Neoplasm Transplantation | |
| Sarcoma, Experimental | |
| Time Factors |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30452663 | Potential lethal damage repair in glioblastoma cells irradiated with ion beams of various types and levels of linear energy transfer. | J Radiat Res | 2019 | https://conductscience.org/library/papers/30452663 | PubMed |
| 7000126 | Can dose-survival parameters be deduced from in situ assays? | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000126 | PubMed |
| 7000122 | Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000122 | PubMed |
| 6678862 | In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl-nitrosoureas and dianhydrogalactitol. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678862 | PubMed |
| 6678861 | Heterogeneous responses of an in vitro model of human stomach cancer to anticancer drugs. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678861 | PubMed |
| 6607738 | PLDR inhibitors: their biological and clinical implications. | Br J Cancer Suppl | 1984 | https://conductscience.org/library/papers/6607738 | PubMed |
| 6177286 | Modulation of bleomycin cytotoxicity. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6177286 | PubMed |
| 6157635 | Effect of tumor dissaggregation on results of in vitro cell survival assay after in vivo treatment of the EMT-6 tumor: x-rays, cyclophosphamide, and bleomycin. | In Vitro | 1980 | https://conductscience.org/library/papers/6157635 | PubMed |
| 4131499 | The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to 1,3-bis(2-chloroethyl)-1-nitrosourea. | Br J Cancer | 1973 | https://conductscience.org/library/papers/4131499 | PubMed |
| 2579666 | Bleomycin and misonidazole cytotoxicity. | Br J Cancer | 1985 | https://conductscience.org/library/papers/2579666 | PubMed |
| 2254382 | Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time. | J Cancer Res Clin Oncol | 1990 | https://conductscience.org/library/papers/2254382 | PubMed |
| 1184035 | Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor. | In Vitro | 1975 | https://conductscience.org/library/papers/1184035 | PubMed |
| 921888 | Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. | Br J Cancer | 1977 | https://conductscience.org/library/papers/921888 | PubMed |
| 889685 | Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. | Br J Cancer | 1977 | https://conductscience.org/library/papers/889685 | PubMed |
| 75740 | Studies with bleomycin and misonidazole on aerated and hypoxic cells. | Br J Cancer | 1978 | https://conductscience.org/library/papers/75740 | PubMed |
| 55271 | Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. | Br J Cancer | 1975 | https://conductscience.org/library/papers/55271 | PubMed |
| 48253 | Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/48253 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4121931
GET https://conductscience.org/api/papers/v1/4121931/authors